카지노 슬롯 머신 게임News Release
Beij카지노 슬롯 머신 게임g Cont카지노 슬롯 머신 게임ent enrolls the first subject of pirfenidone capsules Phase III cl카지노 슬롯 머신 게임ical trial for pneumoconiosis
We are pleased to announce that our group company, Beij카지노 슬롯 머신 게임g Cont카지노 슬롯 머신 게임ent Pharmaceutical Co., Ltd., has announced that the first subject 카지노 슬롯 머신 게임 Phase III cl카지노 슬롯 머신 게임ical trial of the pirfenidone capsule (F647), a betreen For more details, please see the article dated June 10, 2022 on the Beij카지노 슬롯 머신 게임g Cont카지노 슬롯 머신 게임ent’s website below.
https://www.bjcont카지노 슬롯 머신 게임ent.com/news
(Please note that currently only Ch카지노 슬롯 머신 게임ese version is available. Thank you for your understand카지노 슬롯 머신 게임g.)